Gloria Dalla Costa

Biography

Publications

• Neurofilament light biomarkers in MS: Effects of extended natalizumab dosing.

  Dalla Costa G, Haghikia A, Gold R, Furlan R, Comi G. Mult Scler 2025 Feb 11

  PMID: 39931832

• An overview on disease modifying and symptomatic drug treatments for multiple sclerosis.

  Dalla Costa G, Leocani L, Rodegher M, Chiveri L, Gradassi A, Comi G. Expert Rev Clin Pharmacol 2024 Oct 08

  PMID: 39376160

• Assessing disease progression and treatment response in progressive multiple sclerosis.

  Comi G, Dalla Costa G, Stankoff B, Hartung HP, Soelberg Sørensen P, Vermersch P, Leocani L. Nat Rev Neurol 2024 10

  PMID: 39251843

• Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics.

  Omrani M, Chiarelli RR, Acquaviva M, Bassani C, Dalla Costa G, Montini F, Preziosa P, Pagani L, Grassivaro F, Guerrieri S, Romeo M, Sangalli F, Colombo B, Moiola L, Zaffaroni M, Pietroboni A, Protti A, Puthenparampil M, Bergamaschi R, Comi G, Rocca MA, Martinelli V, Filippi M, Farina C. Brain Behav Immun 2024

  PMID: 39097200

• Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres.

  Dalla Costa G, Leocani L, Pisa M, Croese T, Martinelli V, Moiola L, Sangalli F, Colombo B, Haghikia A, Gold R, Furlan R, Comi G. Mult Scler 2024

  PMID: 38877721